Diagnosed with SMM, SPB, or MGUS?
Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
Category Archives for Pre-Myeloma
Treatment vs. Watchful Waiting-Smoldering Multiple Myeloma
“Trials of lenalidomide (revlimid) in a less intensive approach has shown promise in delaying disease progression and should be investigated further in clinical trials.” You’ve been diagnosed
Continue readingSingle Plasmacytoma, MGUS, SMM Demystified
Plasmacytoma, MGUS and SMM Defined- Symptoms, Causes, Diagnostics- Hi. My name is David Emerson. I am a the Director of PeopleBeatingCancer, long-term Multiple Myeloma survivor and Multiple Myeloma cancer
Continue readingPredicting Overall Survival of Solitary Bone Plasmacytoma
“The multivariable regression analysis was performed to obtain the significant prognosis that was used to establish the nomogram for 3-, 5-, and 10-year OS.” I was diagnosed with a single bone
Continue readingChemotherapy for Smoldering Multiple Myeloma???
“Nonhematologic grade 3 adverse events occurred in 21 patients (38.9%) and included thromboembolism, rash, and lung infection, with no grade 4 events.” Yes, chemotherapy can slow the progression
Continue readingMGUS Dx- Cure vs. Control?
MGUS patients are more likely to develop more severe PN during treatment with certain drugs used to treat MM (e.g. bortezomib and thalidomide) Hi David- I was diagnosed with Monoclonal Gammopathy
Continue readingSmoldering Multiple Myeloma (SMM) – Chemo now, later?
“New studies (pre-habilitation) suggest that a multimodal approach that incorporates both physical and psychological prehabilitation interventions may be more effective than a unimodal approach that
Continue readingPre- Myeloma? Stage 1 Multiple Myeloma? Cure vs. Control
Should we treat patients with myeloma with multidrug, multitransplant combinations with the goal of potentially curing a subset of patients, recognizing that the risk of adverse events and effect on quality
Continue readingRisk of Progression for Smoldering Multiple Myeloma is Reduced…at what cost?
“Lenalidomide (Revlimid) induced a 72% reduction in the risk of progression to symptomatic disease in patients with smoldering multiple myeloma at 3 years” The challenge with pre-myeloma, Monoclonal
Continue readingRheumatologic Disease Inc. Risk of MGUS to Multiple Myeloma
“Patients with monoclonal gammopathy of undetermined significance (MGUS) have twice the risk of developing multiple myeloma (MM) if they have non-antibody (Ab)-mediated rheumatic diseases (RDs)…” Rheumatic
Continue readingMGUS, Myeloma AL Amyloidosis- Conventional, Non-Conventional
“Bortezomib with dexamethasone as first-line treatment for AL amyloidosis with renal involvement…in multiple myeloma or MGUS patients?” You’ve been diagnosed with multiple myeloma
Continue reading